Useful resources |
Purine Antagonists for Chronic Lymphocytic Leukaemia (Cochrane Review) ABSTRACT Background: Recent trials suggest improved response rates for purine antagonists compared to alkylator-based regimens in the treatment of B-CLL. However, none was able to show a survival advantage. |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |